The Patent Finder

Terms ending in 2034

Merck Sharp and Dohme LLC

Every in-force patent on Merck Sharp and Dohme LLC's record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 9,315,475HIV Protease Inhibitors
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 9,550,7864-Fluoropiperidine Orexin Receptor Antagonists
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 9,446,130BTK Inhibitors
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 9,394,308Inhibiting the Transient Receptor Potential A1 Ion Channel
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 9,481,682Substituted Benzamides and Substituted Pyridinecarboxamides as BTK Inhibitors
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 9,540,3772,6,7,8 Substituted Purines as HDM2 Inhibitors
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 9,242,998Tetracyclic Heterocycle Compounds and Methods of Use Thereof for the Treatment of Hepatitis C
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 9,243,002Tetracyclic Heterocycle Compounds and Methods of Use Thereof for the Treatment of Hepatitis C
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 9,493,461Tetracyclic Heterocycle Compounds and Methods of Use Thereof for the Treatment of Hepatitis C
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 9,682,9782,6,7 Substituted Purines as HDM2 Inhibitors
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
152 more term ends in 2034 · Pro
10 of 162 patents shown. Soonest term end first, then patent number.
Pro members see all 162.
Upgrade to Pro
155 of these are in force and held by Merck Sharp and Dohme LLC.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited